TalkMed Group Ltd operates as an investment holding company. The principal activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services, and Stem Cells Services. The Oncology Services segment provides specialist medical oncology services to Parkway Cancer Centre. Stem Cells Services is engaged in the provision of stem cells services related to processing, culturing and storage of stem cells mainly to Parkway Cancer Centre. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.